RU2008140653A - Производные прегабалина для лечения фибромиалгии и других расстройств - Google Patents
Производные прегабалина для лечения фибромиалгии и других расстройств Download PDFInfo
- Publication number
- RU2008140653A RU2008140653A RU2008140653/15A RU2008140653A RU2008140653A RU 2008140653 A RU2008140653 A RU 2008140653A RU 2008140653/15 A RU2008140653/15 A RU 2008140653/15A RU 2008140653 A RU2008140653 A RU 2008140653A RU 2008140653 A RU2008140653 A RU 2008140653A
- Authority
- RU
- Russia
- Prior art keywords
- pain
- use according
- disease
- fibromyalgia
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Transplantation (AREA)
- Reproductive Health (AREA)
- Anesthesiology (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1. Применение (3S,5R)-3-аминометил-5-метилоктановой кислоты или ее фармацевтически приемлемой соли для получения лекарственного средства для лечения у млекопитающего заболевания, выбранного из фибромиалгии, боли в животе или боли гинекологического происхождения и боли, вызванной усиленными сокращениями мочевого пузыря. ! 2. Применение по п.1, где млекопитающим является человек. ! 3. Применение по любому из п.1 или 2, где заболевание представляет собой фибромиалгию. ! 4. Применение по любому из пп.1 или 2, где заболевание представляет собой боль, вызванную усиленными сокращениями мочевого пузыря. ! 5. Применение по любому из п.1 или 2, где заболевание представляет собой боль в животе или боль гинекологического происхождения. ! 6. Применение по п.5, где боль представляет собой дисменорею. ! 7. Применение по п.5, где боль представляет собой боль при родах. ! 8. Применение по п.5, где боль представляет собой боль, связанную с эндометриозом.
Claims (8)
1. Применение (3S,5R)-3-аминометил-5-метилоктановой кислоты или ее фармацевтически приемлемой соли для получения лекарственного средства для лечения у млекопитающего заболевания, выбранного из фибромиалгии, боли в животе или боли гинекологического происхождения и боли, вызванной усиленными сокращениями мочевого пузыря.
2. Применение по п.1, где млекопитающим является человек.
3. Применение по любому из п.1 или 2, где заболевание представляет собой фибромиалгию.
4. Применение по любому из пп.1 или 2, где заболевание представляет собой боль, вызванную усиленными сокращениями мочевого пузыря.
5. Применение по любому из п.1 или 2, где заболевание представляет собой боль в животе или боль гинекологического происхождения.
6. Применение по п.5, где боль представляет собой дисменорею.
7. Применение по п.5, где боль представляет собой боль при родах.
8. Применение по п.5, где боль представляет собой боль, связанную с эндометриозом.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43349102P | 2002-12-13 | 2002-12-13 | |
| US60/433,491 | 2002-12-13 | ||
| US48774003P | 2003-07-16 | 2003-07-16 | |
| US60/487,740 | 2003-07-16 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2005118081/14A Division RU2353358C2 (ru) | 2002-12-13 | 2003-12-03 | Производные прегабалина для лечения приливов |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2008140653A true RU2008140653A (ru) | 2010-04-20 |
Family
ID=32600153
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2005118081/14A RU2353358C2 (ru) | 2002-12-13 | 2003-12-03 | Производные прегабалина для лечения приливов |
| RU2008140653/15A RU2008140653A (ru) | 2002-12-13 | 2008-10-13 | Производные прегабалина для лечения фибромиалгии и других расстройств |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2005118081/14A RU2353358C2 (ru) | 2002-12-13 | 2003-12-03 | Производные прегабалина для лечения приливов |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20090203782A1 (ru) |
| EP (2) | EP2172197A1 (ru) |
| JP (1) | JP2006513257A (ru) |
| KR (1) | KR20050085636A (ru) |
| CN (1) | CN101862317A (ru) |
| AU (1) | AU2003303040B2 (ru) |
| BR (1) | BR0317253A (ru) |
| CA (1) | CA2505788A1 (ru) |
| MX (1) | MXPA05006320A (ru) |
| NO (1) | NO20052264L (ru) |
| NZ (1) | NZ540591A (ru) |
| PL (1) | PL377520A1 (ru) |
| RU (2) | RU2353358C2 (ru) |
| TW (1) | TW200423925A (ru) |
| WO (1) | WO2004054566A1 (ru) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004089289A2 (en) | 2003-03-31 | 2004-10-21 | Xenoport, Inc. | Treating or preventing hot flashes using prodrugs of gaba analogs |
| KR20060087560A (ko) * | 2003-09-12 | 2006-08-02 | 워너-램버트 캄파니 엘엘씨 | 알파-2-델타 리간드 및 ｓｓｒｉ 및/또는 ｓｎｒｉ를포함하는 우울증 및 불안 장애 치료용 조합물 |
| US20070141684A1 (en) | 2005-12-21 | 2007-06-21 | Pfizer Inc | Preparation of gamma-amino acids having affinity for the alpha-2-delta protein |
| SG11201606351VA (en) | 2014-02-03 | 2016-09-29 | Quadriga Biosciences Inc | Beta-substituted beta-amino acids and analogs as chemotherapeutic agents |
| EP3102194A1 (en) * | 2014-02-03 | 2016-12-14 | Quadriga Biosciences, Inc. | Beta-substituted gamma-amino acids and analogs as chemotherapeutic agents |
| US9783487B2 (en) | 2015-08-03 | 2017-10-10 | Quadriga Biosciences, Inc. | Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof |
| CN115739134B (zh) * | 2022-11-24 | 2024-08-02 | 贵州大学 | 一种利用三氯化钌废弃物制备氯乙烯合成用复合催化剂的方法 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2460891C2 (de) | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US4087544A (en) | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
| ES2165857T3 (es) * | 1992-05-20 | 2002-04-01 | Univ Northwestern | Analogos de gaba y acido l-glutamico para el tratamiento de trastornos del sistema nervioso central. |
| DE69323212T2 (de) | 1992-12-17 | 1999-05-27 | Pfizer Inc., New York, N.Y. | Pyrazole mit crf antagonistischer aktivität |
| TW370529B (en) | 1992-12-17 | 1999-09-21 | Pfizer | Pyrazolopyrimidines |
| AU690079B2 (en) | 1992-12-17 | 1998-04-23 | Pfizer Inc. | Substituted pyrazoles as CRF antagonists |
| TW336932B (en) | 1992-12-17 | 1998-07-21 | Pfizer | Amino-substituted pyrazoles |
| DK0674641T3 (da) | 1992-12-17 | 1999-09-27 | Pfizer | Pyrrolopyrimidiner som CRF-antagonister |
| US5670539A (en) * | 1993-07-21 | 1997-09-23 | New York State Office Of Mental Health | Treatment of movement disorders using large neutral amino acids |
| US6372792B1 (en) * | 1996-04-26 | 2002-04-16 | Guy Chouinard | Method for treating anxiety, anxiety disorders and insomnia |
| KR100491282B1 (ko) * | 1996-07-24 | 2005-05-24 | 워너-램버트 캄파니 엘엘씨 | 통증 치료용 이소부틸가바 및 그의 유도체 |
| SE9603408D0 (sv) * | 1996-09-18 | 1996-09-18 | Astra Ab | Medical use |
| WO1998017627A1 (en) | 1996-10-23 | 1998-04-30 | Warner-Lambert Company | Substituted gamma aminobutyric acids as pharmaceutical agents |
| US6127418A (en) * | 1997-08-20 | 2000-10-03 | Warner-Lambert Company | GABA analogs to prevent and treat gastrointestinal damage |
| CN1303059C (zh) | 1997-10-27 | 2007-03-07 | 沃尼尔·朗伯公司 | 作为药物的环状氨基酸及其衍生物 |
| CA2333024C (en) | 1998-07-09 | 2002-03-26 | Warner-Lambert Company | Method for the treatment of insomnia |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| EP1169060B1 (en) * | 1999-04-09 | 2005-08-31 | Euro-Celtique S.A. | Sodium channel blocker compositions and the use thereof |
| US6642398B2 (en) * | 1999-06-10 | 2003-11-04 | Warner-Lambert Company | Mono-and disubstituted 3-propyl gamma-aminobutyric acids |
| MXPA01012319A (es) | 1999-06-10 | 2002-07-22 | Warner Lambert Co | Acidos 3-propil gama aminobutiricos mono y disubstituidos. |
| US7164034B2 (en) * | 1999-06-10 | 2007-01-16 | Pfizer Inc. | Alpha2delta ligands for fibromyalgia and other disorders |
| US6309663B1 (en) * | 1999-08-17 | 2001-10-30 | Lipocine Inc. | Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| ATE359068T1 (de) * | 1999-07-22 | 2007-05-15 | Univ Rochester | Methode zur behandlung der symptome hormoneller veränderungen, einschliesslich hitzewallungen |
| US6281207B1 (en) * | 1999-09-15 | 2001-08-28 | Reed Richter | Treatment of movement disorders by administration of mirtazapine |
| HN2000000224A (es) | 1999-10-20 | 2001-04-11 | Warner Lambert Co | Aminoacidos biciclicos como agentes farmaceuticos |
| GB2362646A (en) | 2000-05-26 | 2001-11-28 | Warner Lambert Co | Cyclic amino acid derivatives useful as pharmaceutical agents |
| GB2365425A (en) * | 2000-08-01 | 2002-02-20 | Parke Davis & Co Ltd | Alkyl amino acid derivatives useful as pharmaceutical agents |
| US20020099013A1 (en) * | 2000-11-14 | 2002-07-25 | Thomas Piccariello | Active agent delivery systems and methods for protecting and administering active agents |
| IL145584A0 (en) * | 2000-10-02 | 2002-06-30 | Pfizer Prod Inc | Nmda nr2b antagonists for treatment |
| WO2002069974A1 (en) * | 2001-03-05 | 2002-09-12 | Andrew Holman | Administration of sleep restorative agents |
| MXPA03009392A (es) * | 2001-05-25 | 2004-01-29 | Warner Lambert Co | Composicion famaceutica liquida. |
-
2003
- 2003-12-03 RU RU2005118081/14A patent/RU2353358C2/ru not_active IP Right Cessation
- 2003-12-03 BR BR0317253-8A patent/BR0317253A/pt not_active IP Right Cessation
- 2003-12-03 JP JP2005502471A patent/JP2006513257A/ja active Pending
- 2003-12-03 MX MXPA05006320A patent/MXPA05006320A/es active IP Right Grant
- 2003-12-03 NZ NZ540591A patent/NZ540591A/en unknown
- 2003-12-03 PL PL377520A patent/PL377520A1/pl not_active Application Discontinuation
- 2003-12-03 EP EP09175270A patent/EP2172197A1/en not_active Withdrawn
- 2003-12-03 KR KR1020057010833A patent/KR20050085636A/ko not_active Ceased
- 2003-12-03 EP EP03813230A patent/EP1572188A1/en not_active Withdrawn
- 2003-12-03 CA CA002505788A patent/CA2505788A1/en not_active Abandoned
- 2003-12-03 AU AU2003303040A patent/AU2003303040B2/en not_active Ceased
- 2003-12-03 WO PCT/IB2003/005712 patent/WO2004054566A1/en not_active Ceased
- 2003-12-03 CN CN201010165706A patent/CN101862317A/zh active Pending
- 2003-12-12 TW TW092135197A patent/TW200423925A/zh unknown
-
2005
- 2005-05-10 NO NO20052264A patent/NO20052264L/no not_active Application Discontinuation
-
2008
- 2008-10-13 RU RU2008140653/15A patent/RU2008140653A/ru unknown
-
2009
- 2009-04-20 US US12/426,501 patent/US20090203782A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TW200423925A (en) | 2004-11-16 |
| NZ540591A (en) | 2008-03-28 |
| BR0317253A (pt) | 2005-11-01 |
| MXPA05006320A (es) | 2005-08-26 |
| RU2353358C2 (ru) | 2009-04-27 |
| EP1572188A1 (en) | 2005-09-14 |
| NO20052264D0 (no) | 2005-05-10 |
| WO2004054566A1 (en) | 2004-07-01 |
| US20090203782A1 (en) | 2009-08-13 |
| CN101862317A (zh) | 2010-10-20 |
| AU2003303040B2 (en) | 2009-04-23 |
| EP2172197A1 (en) | 2010-04-07 |
| CA2505788A1 (en) | 2004-07-01 |
| KR20050085636A (ko) | 2005-08-29 |
| NO20052264L (no) | 2005-09-12 |
| JP2006513257A (ja) | 2006-04-20 |
| RU2005118081A (ru) | 2006-01-20 |
| AU2003303040A1 (en) | 2004-07-09 |
| PL377520A1 (pl) | 2006-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2008140653A (ru) | Производные прегабалина для лечения фибромиалгии и других расстройств | |
| EP1443928A4 (en) | TREATMENT OF NEURODEGENERATIVE DISEASES AND CANCER IN THE BRAIN | |
| EA200400881A1 (ru) | Азаарилпиперазины | |
| LU92520I2 (fr) | Bédaquiline, ou son sel d'addition d'acide ou de base pharmaceutiquement acceptable, y compris le fumarate de bédaquiline | |
| EA201100506A1 (ru) | Комбинация ингибитора протеазы ns3 hcv с интерфероном и рибавирином | |
| RU2008127882A (ru) | Лечение пищевода барретта | |
| RU2003119858A (ru) | Комбинированный хирургический способ лечения ректоцеле | |
| RU2003112195A (ru) | Способ пластики мочеиспускательного канала по поводу его протяженной или рецидивирующей стриктуры, облитерации или свища | |
| RU2004116737A (ru) | Способ дифференциальной оценки состояния плода | |
| CN209751250U (zh) | 一种新型橡皮链 | |
| RU2001120730A (ru) | Способ позадилонной кольпосуспензии при стрессовом недержании мочи женщин | |
| RU2004102626A (ru) | Способ хирургического лечения осложненных язв желудка | |
| Ford et al. | Treatment of complete rectal prolapse and its complications | |
| RU2003109909A (ru) | Средство для лечения заболеваний глаз с метронидазолом и оксиметилурацилом | |
| RU2004130782A (ru) | Способ анестезии при оперативных вмешательствах на органах брюшной полости | |
| DK1818052T3 (da) | Anvendelse af formoterol i den profylaktiske og/eller terapeutiske behandling af muskelsvind og/eller kakektisk syndrom i forbindelse med kataboliske forhold af visse sygdomme såsom cancer, aids, infektioner, diabetes og andre | |
| RU2000112589A (ru) | Способ лапароскопической аппаратной гистерэктомии | |
| RU2003121578A (ru) | Способ восстановления функции тазовых органов | |
| RU2009134587A (ru) | Способ формирования колостомы | |
| RU2002126534A (ru) | Способ непрямого доступа в полость двенадцатиперстной кишки | |
| RU2526286C2 (ru) | Бандаж и способ его применения при лечении и профилактике послеродовых заболеваний коров | |
| RU2002119600A (ru) | Способ лечения воспалительных заболеваний женских половых органов | |
| PL1514545T3 (pl) | Zastosowanie tolperyzonu do leczenia skurczów narządów zbudowanych zasadniczo z mięśni gładkich | |
| RU2003107613A (ru) | Способ профилактики гнойно-септических осложнений у родильниц после кесарева сечения | |
| RU2004112063A (ru) | Способ профилактики эндометрита после кесарева сечения |